Westwood Management Corp IL held its stake in Waters Co. (NYSE:WAT) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,900 shares of the medical instruments supplier’s stock at the end of the first quarter. Westwood Management Corp IL’s holdings in Waters were worth $453,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of WAT. Creative Planning increased its stake in Waters by 1.6% in the first quarter. Creative Planning now owns 744 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 12 shares during the period. Quadrant Capital Group LLC increased its stake in Waters by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 822 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 35 shares during the period. Advisor Group Inc. increased its stake in Waters by 1.0% in the third quarter. Advisor Group Inc. now owns 956 shares of the medical instruments supplier’s stock valued at $131,000 after buying an additional 9 shares during the period. Woodmont Investment Counsel LLC bought a new stake in Waters during the third quarter valued at $139,000. Finally, Van ECK Associates Corp increased its stake in Waters by 7.2% in the fourth quarter. Van ECK Associates Corp now owns 1,051 shares of the medical instruments supplier’s stock valued at $141,000 after buying an additional 71 shares during the period. 92.53% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Waters Co. (NYSE:WAT) traded down 0.30% on Friday, reaching $158.52. 289,499 shares of the company traded hands. The stock’s 50 day moving average price is $155.95 and its 200 day moving average price is $147.00. The company has a market capitalization of $12.70 billion, a PE ratio of 24.73 and a beta of 0.83. Waters Co. has a one year low of $128.90 and a one year high of $162.53.

Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, January 24th. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.13 by $0.08. The company had revenue of $629 million for the quarter, compared to the consensus estimate of $616.85 million. Waters had a net margin of 24.06% and a return on equity of 24.47%. The firm’s revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.96 earnings per share. On average, equities research analysts predict that Waters Co. will post $7.04 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Financial Market News and is the sole property of of Financial Market News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at http://www.financial-market-news.com/westwood-management-corp-il-has-453000-position-in-waters-co-wat/1406359/.

WAT has been the subject of several research analyst reports. Cantor Fitzgerald set a $170.00 price target on shares of Waters and gave the company a “buy” rating in a research note on Tuesday, January 24th. Deutsche Bank AG reiterated a “buy” rating and set a $160.00 price objective on shares of Waters in a report on Wednesday, January 18th. Zacks Investment Research upgraded shares of Waters from a “sell” rating to a “hold” rating in a report on Thursday, January 26th. Jefferies Group LLC lifted their price objective on shares of Waters from $147.00 to $150.00 and gave the company a “hold” rating in a report on Friday, March 3rd. Finally, Barclays PLC reiterated a “hold” rating and set a $148.00 price objective on shares of Waters in a report on Monday, January 9th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $157.67.

In other Waters news, SVP Rohit Khanna sold 1,078 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The shares were sold at an average price of $153.50, for a total transaction of $165,473.00. Following the sale, the senior vice president now owns 4,077 shares in the company, valued at approximately $625,819.50. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP David Terricciano sold 27,340 shares of the firm’s stock in a transaction that occurred on Thursday, February 9th. The stock was sold at an average price of $148.22, for a total transaction of $4,052,334.80. Following the sale, the senior vice president now owns 9,652 shares in the company, valued at approximately $1,430,619.44. The disclosure for this sale can be found here. In the last three months, insiders sold 74,418 shares of company stock worth $10,915,868. 5.45% of the stock is currently owned by insiders.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

5 Day Chart for NYSE:WAT

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Receive News & Ratings for Waters Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Co. and related companies with MarketBeat.com's FREE daily email newsletter.